MTX-211

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMTX-211
Drug Alias NameMTX-211
ClassificationSmall molecules
Mechanisms of ActionPI3-kinase class I inhibitorsEpidermal growth factor receptor erbB1 antagonists
TargetsPI3-kinase class IEpidermal growth factor receptor erbB1
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMekanistic Therapeutics LLCUniversity Of Michigan
China Registration ClassN/A

Develop Information

Active CompaniesMekanistic Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A